Category: Biomarkers
Global Biomarkers
-
2023 Global Cancer Diagnostics Market in the USA, Europe, Japan-2022 Supplier Shares and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... and analysis not available from any other published source , including 2022 supplier strategies and shares by country, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists ... Read More
-
Global Liquid Biopsy Market – Analysis by Biomarker Type (CTCs, ctDNA, EVs, Others), Product (Assay Kits, Instruments and Devices, Services), By Indication By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)
... Executive Summary The Global Liquid Biopsy Market was valued at USD 2.2 Billion in the year 2021 backed by several initiatives to raise cancer awareness launched by governments and global health organizations over the last ... Read More
-
Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarray), Flow Cytometry, Microfluidics, Immunoassay, Biomarker, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)
... Syndromic Panel-Based Testing, and Microarray), Flow Cytometry, Microfluidics, Immunoassay, Biomarker, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User ... Read More
-
Renal Biomarkers: Technologies and Global Markets
... regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and ... Read More
-
2023 Global Forecast for Cardiac Marker Testing Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales ... Read More
-
Healthcare Analytical Testing Services Market by Type (Biomarker Testing, Stability Testing, Raw Material Testing, Batch-release Testing, Cleaning Validation, End User (Pharmaceutical Companies, Medical Device Companies, CRO) - Global Forecast to 2027
... services market is projected to reach USD 11.1 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 11.4%. Growth in the market is driven by the rising trend of outsourcing of ... Read More
-
Microarray Market 2022-2028
... technology has a wide range of applications and found its increasing use in pharmaceutical target screening, drug discovery, basic molecular biology, biomarker identification, and others. The microarray technology can facilitate the analysis of thousands of ... Read More
-
Global Liquid Biopsy Market: Analysis By Product & Services (Kits & Reagents, Platforms & Instruments and Services), By Circulating Biomarker (Circulating Tumor Cell, CT-DNA, Extracellular Vesicles, and Others), By End-User (Hospitals & Laboratories, and Government & Academic Research Centers), By Application (Cancer, and Non Cancer) By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027
... & Academic Research Centers), By Application (Cancer, and Non Cancer) By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027 The global liquid biopsy market in 2021 stood at US$1.28 billion, ... Read More
-
Global Cardiac Biomarkers Market - 2022-2029
... CAGR of 10.5% during the forecast period (2022-2029). Cardiac biomarkers are biological molecules released into the blood as the heart is damaged or under stress. Identifying and estimating such biomarkers help diagnose acute coronary syndrome ... Read More
-
Alzheimer’s Disease Biomarkers Market (Type of Biomarker: CSF Biomarkers, Genetic Biomarkers, and Blood Biomarkers; and Detection Technique; Molecular Diagnostics and Immunoassays) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Market – Scope of Report TMR’s report on the global alzheimer’s disease biomarkers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the ... Read More
-
Liquid Biopsy Market by Product (Assay Kits, Instruments), Circulating Biomarkers (CTC, ctDNA), Technology (NGS, PCR), Application (Cancer (Lung, Breast), Non-Cancer), Sample Type (Blood), End User (Reference Lab, Hospitals) - Global Forecast to 2027
... liquid biopsy market is projected to reach USD 10.0 billion by 2027 from USD 4.3 billion in 2022, at a CAGR of 18.3% during the forecast period. Market growth is driven by factors such as ... Read More
-
Tissue Diagnostics Market by Product Type (Antibodies, Kits, Reagents, Instruments [Slide Stainer, Scanner]), Technology (Digital Pathology, IHC, ISH, H&E Staining), Cancer Type (Breast, NSCLC, Colorectal, Prostate), and End user - Global Forecast to 2029
... market is projected to reach $8.52 billion by 2029, at a CAGR of 7.4% from 2022 to 2029. Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out ... Read More
-
Cancer/Tumor Profiling Market by Technology (Immunoassay, NGS, PCR), Cancer Type (Breast, Lung, Colorectal), Biomarker Type (Genomic Biomarkers, Protein Biomarkers), Application (Biomarker Discovery, Diagnostics, Prognostics) - Global Forecast to 2027
... projected to reach USD 16.0 Billion by 2027 from USD 9.7 Billion in 2022, at a CAGR of 10.6% during the forecast period. Growth in this market is majorly driven by rising funding investments in ... Read More
-
Digital Biomarkers Market Size, Share & Trends Analysis Report By Product Type (Wearable Application, Mobile Application, Portables), By End-user (Healthcare Companie, Healthcare Services, Others) By Region, And Segment Forecasts, 2022 - 2027
... biomarkers market size was valued at US$2.3 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 25.7% during 2022-2027. The digital biomakers in healthcare market report provides an ... Read More
-
In Situ Hybridization Market by Products (Consumables, Instruments, Software), Technology (DNA FISH, RNA FISH, PNA FISH, CISH), Application (Cancer, Immunology, Neuroscience, Cytology), End User (Hospitals, Pharma, Biotech, CROs) – Global Forecast to 2027
... in situ hybridization market is projected to reach USD 2.8 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 12.6% during the forecast period. Companion diagnostic products showcase a significant potential ... Read More
-
Global Metabolomics Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product and Services (Metabolomics Instrument, Metabolomics bioinformatics tools and services), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Metabolic Disorders), Application (Biomarker Discovery, Toxicology, Nutrigenomics, Personalized Medicine, Drug Discovery, Functional Genomics) and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
... Discovery, Toxicology, Nutrigenomics, Personalized Medicine, Drug Discovery, Functional Genomics) and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) Market Overview: The scientific study of chemical processes, including metabolites, is known as ... Read More
-
Global Biomarkers Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Type (Molecular, Radiographic, Histologic, Physiologic), Application (Disease Susceptibility/Risk, Diagnostic, Drug Discovery & Development, Personalized Medicine, and Others), Disease (Oncology, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders) and Regions (North America, Asia Pacific, Europe, Latin America Middle East and Africa)
... Disorders) and Regions (North America, Asia Pacific, Europe, Latin America Middle East and Africa) Market Overview: Biomarkers are biological measures used to conduct a diagnostic evaluation, such as blood pressure or cholesterol level, as well ... Read More
-
Precision Psychiatry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027Segmented By Biomarkers (Genetic v/s Protein), By Sample (Blood Based v/s Non-Blood-Based), By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others), By Application (Alzheimer’s Disease, Parkinson’s Disease, Autism, Depression, Others), By End User (Hospital & Clinics, Academic & Research Institutions, Others), By Company and By Region
... (Alzheimer’s Disease, Parkinson’s Disease, Autism, Depression, Others), By End User (Hospital & Clinics, Academic & Research Institutions, Others), By Company and By Region The global precision psychiatry market is anticipated to observe impressive growth during ... Read More
-
Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)
... period (2022-2027). The COVID-19 pandemic led to a lot of disruption in almost every industry vertical. The healthcare sector also faced a similar unprecedented impact across several domains. However, the impact of the outbreak on ... Read More
-
Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
... and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Specific Proteins pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Cancer Diagnostics Market (Test Type: Tumor Biomarker Tests, Imaging, Endoscopy, and Biopsy; End-user: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... – Scope of Report TMR’s report on the global cancer diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during ... Read More
-
Global Saliva Collection and Diagnosis Market Size study & Forecast, by Site of Collection (Parotid Gland Collection, Submandibular Collection, and Minor Salivary Glands Collection), By Application (Diagnostic Laboratories, Forensic and Others), and Regional Analysis, 2022-2029
... Global Saliva Collection and Diagnosis Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. ... Read More
-
Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hs-CRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) - Global Forecast to 2027
... cardiac marker testing market is projected to reach USD 7.7 Billion by 2027 from USD 5.0 Billion in 2022, at a CAGR of 8.7% during the forecast period. The growth in the cardiac marker testing ... Read More
-
Global Minimally Invasive Biopsy Techniques Market By Product Offered (Tests, Kits & Consumables, Instruments), By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others {Breath Biopsy etc.}), By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others {miRNA, CTECs, circRNA etc.}), By Application (Clinical v/s Therapeutic), By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions), By Region, Competition Forecast & Opportunities, 2027
... (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others {miRNA, CTECs, circRNA etc.}), By Application (Clinical v/s Therapeutic), By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions), By ... Read More
-
Patient Derived Xenograft/PDX Models
... estimated at US$115.7 Million in the year 2020, is projected to reach a revised size of US$333.2 Million by 2027, growing at aCAGR of 16.3% over the period 2020-2027. Mice Model, one of the segments ... Read More
Research Assistance
